Mpc

Developer of new generation of small molecules for cancer and degenerative diseases

placePlan Les Ouates, Geneva, Switzerland calendar_todayFounded 2018 language mpc-therapeutics.com

Social engagement

Social engagement: 1.6K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Fongit, Plutus Investment Group.

Investor typeCountShare
Venture capital133%
Accelerator & incubator267%

Recent activity

29 Jun 2026
Milestone
satri-cel
4 May 2026
Event
ISCT2026
24 Apr 2026
Event
ISCT2026
Coming soon